Inventiva S.A. (IVA)
NASDAQ·Healthcare·Biotechnology
$5.02
-2.14%
Mkt Cap $331.65M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$15.80
Range $12.00 – $24.00
Implied Upside
+214.7%
Consensus $15.80 vs current $5.02
NASDAQ·Healthcare·Biotechnology
$5.02
-2.14%
Mkt Cap $331.65M
No recent rating data.
Price Target (7 analysts)
$15.80
Range $12.00 – $24.00
+214.7%
Consensus $15.80 vs current $5.02